NCT05817643View on ClinicalTrials.gov

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

February 27, 2023

Study Completion Date

November 15, 2024

Conditions

Alzheimer DiseaseDementia

Interventions

DRUG

BMS-984923

Oral capsule

Trial Locations (1)

53095

Spaulding Clinical Research, West Bend

Sponsors

Lead Sponsor

Allyx Therapeutics

All Listed Sponsors

collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Allyx Therapeutics

INDUSTRY

NCT05817643 - Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers | Biotech Hunter | Biotech Hunter